přejít na obsah
Evolution-adjusted tumor pathophysiology: the novel language of tumor biology Náhled dokumentu
ZavřítNáhled dokumentu
Probíhá kontrola...

Evolution-adjusted tumor pathophysiology: the novel language of tumor biology

Autor Albrecht Reichle
Vydavatel: Dordrecht ; New York : Springer, ©2013.
Vydání/formát:   e-kniha : Document : EnglishZobrazit všechny vydání a formáty
Databáze:WorldCat
Shrnutí:
Combined modularized therapies for metastatic cancer are pointing to central problems of communication among {u2018}systems participators{u2019}. A communication theory explains 'social engineering', endogenously induced or by implementing non-normative boundary conditions. Evolution-adjusted tumor pathophysiology is borne by an evolution theory, which contrasts narrative evolution histories. The tool of  Přečíst více...
Hodnocení:

(ještě nehodnoceno) 0 zobrazit recenze - Buďte první.

Předmětová hesla:
Více podobných

 

Najít online exemplář

Odkazy na tento dokument

Vyhledat exemplář v knihovně

&AllPage.SpinnerRetrieving; Vyhledávání knihoven, které vlastní tento dokument...

Detaily

Žánr/forma: Electronic books
Typ materiálu: Document, Internetový zdroj
Typ dokumentu: Internet Resource, Computer File
Všichni autoři/tvůrci: Albrecht Reichle
ISBN: 9789400768666 9400768664
OCLC číslo: 852664238
Poznámky: Includes index.
Popis: 1 online resource.
Obsahy: Pt. I. Introduction --
pt. II. Combined modularized therapies for metastic tumors : pointing to central problems of communication among 'systems participators' in tumors --
pt. III. Social engineering : biomodulation, either endogenously initiated or by implementation of non-normative boundary conditions --
pt. IV. The tumors' normativity : reconstructing and operationalizing starting points for an evolution theory --
pt. V. Evolution theory --
pt. VI. From genome- or organ-centric to rationalization-centric systematization of tumors --
pt. VII. Reconstruction of tumor-immanent normative functions, structures and decision maxims (hubs) --
pt. VIII. The tool of rationalizations constituting tumor-associated normative notions : the non-genomic counterpart of the tumor genome and therefore, an important therapeutic target for diversifying palliative care --
pt. IX. Novel clinical and pharmaceutical technology for bioengineering tumor response --
pt. X. Objectifying the systems objects' subjectivity in biological systems : a novel reification of the scientific picture about the 'objective' world.
Odpovědnost: Albrecht Reichle, editor.
Více informací:

Anotace:

Evolution-adjusted Tumor Pathophysiology  Přečíst více...

Recenze

Recenze vložené uživatelem
Nahrávání recenzí GoodReads...
Přebírání recenzí DOGO books...

Štítky

Buďte první.
Potvrdit tento požadavek

Tento dokument jste si již vyžádali. Prosím vyberte Ok pokud chcete přesto v žádance pokračovat.

Propojená data


<http://www.worldcat.org/oclc/852664238>
library:oclcnum"852664238"
library:placeOfPublication
library:placeOfPublication
library:placeOfPublication
rdf:typeschema:Book
rdf:typeschema:MediaObject
rdf:valueUnknown value: dct
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:description"Combined modularized therapies for metastatic cancer are pointing to central problems of communication among {u2018}systems participators{u2019}. A communication theory explains 'social engineering', endogenously induced or by implementing non-normative boundary conditions. Evolution-adjusted tumor pathophysiology is borne by an evolution theory, which contrasts narrative evolution histories. The tool of rationalizations constituting the tumor's normativity (inflammation, immune response etc.) represents the non-genomic counterpart of the tumor genome and should be additionally assessed during tumor staging. Evolution-adjusted tumor pathophysiology allows implementing applied systems biology, a novel clinical and pharmaceutical technology for bioengineering tumor response and personalizing tumor therapy. Combined modularized therapy, evolution-adjusted tumor pathophysiology, and {u2018}universal{u2019} biomarkers concertedly address genetically based tumor heterogeneity."
schema:description"Pt. I. Introduction -- pt. II. Combined modularized therapies for metastic tumors : pointing to central problems of communication among 'systems participators' in tumors -- pt. III. Social engineering : biomodulation, either endogenously initiated or by implementation of non-normative boundary conditions -- pt. IV. The tumors' normativity : reconstructing and operationalizing starting points for an evolution theory -- pt. V. Evolution theory -- pt. VI. From genome- or organ-centric to rationalization-centric systematization of tumors -- pt. VII. Reconstruction of tumor-immanent normative functions, structures and decision maxims (hubs) -- pt. VIII. The tool of rationalizations constituting tumor-associated normative notions : the non-genomic counterpart of the tumor genome and therefore, an important therapeutic target for diversifying palliative care -- pt. IX. Novel clinical and pharmaceutical technology for bioengineering tumor response -- pt. X. Objectifying the systems objects' subjectivity in biological systems : a novel reification of the scientific picture about the 'objective' world."
schema:exampleOfWork<http://worldcat.org/entity/work/id/1401855909>
schema:genre"Electronic books"
schema:inLanguage"en"
schema:name"Evolution-adjusted tumor pathophysiology: the novel language of tumor biology"
schema:publication
schema:publisher
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=604820>
schema:url<http://dx.doi.org/10.1007/978-94-007-6866-6>
schema:url<http://lib.myilibrary.com?id=518952>
schema:workExample
wdrs:describedby

Content-negotiable representations

Zavřít okno

Prosím přihlaste se do WorldCat 

Nemáte účet? Můžete si jednoduše vytvořit bezplatný účet.